Simulations Plus Collaborates With Nvidia During AI Drug Modeling Push

Simulations Plus, Inc. (NASDAQ:SLP) shares are trading lower on Wednesday as the company announced a collaboration with NVIDIA Corp (NASDAQ:NVDA), aimed at enhancing GPU-accelerated simulation and AI-assisted workflows in drug development.